Biography

Joyce
de Azavedo is an Associate Professor of Microbiology in the Department
of Laboratory Medicine and Pathobiology at the University of Toronto, Research Scientist at Mount Sinai
Hospital and Director of the Toronto Centre for Antimicrobial
Research and Evaluation (ToCARE). Dr. de Azavedo obtained her
PhD in Microbiology from the Department of Microbiology at Trinity
College, Dublin, Ireland. Following a research
fellowship at the Pasteur Institute, France, she worked in the
Vaccine Research section of the Wellcome Research Laboratories,
England and also at the Samuel Lunenfeld Research Institute of
Mount Sinai Hospital. Her interests and background include the
molecular study of Gram-positive bacterial virulence determinants
and antibiotic resistance mechanisms. Recent studies include the
development of a novel murine pneumonia model for the investigation
of drug efficacy and emergence of resistance and identification
of novel virulence determinants in Group A Streptococcus and Streptococcus
iniae. characterization of using a novel characterization
of virulence.

Dr.
de Azavedo has presented her work at numerous national and
international conferences, and has published several papers in
high-impact peer-reviewed infectious diseases journals including
Infection and Immunity, Molecular Microbiology, Antimicrobial
Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy,
New England Journal of Medicine and Clinical Infectious Diseases.
She has also has written a review article on Fluoroquinolone Resistance
and a book chapter on Streptolysin S. She is a reviewer for the
Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and
Chemotherapy, Journal of Clinical Microbiology and an occasional
reviewer for Infection and Immunity. Dr. de Azavedo has held or
is currently holding research grants from Bayer, Sanofi–Aventis,
Oscient, Merck Frosst, Ortho-McNeil, Bristol Myers Squibb, Roche,
GlaxoSmithkline and the Centers for Disease Control.